ArticleNanomaterials (Basel, Switzerland)2020
Design and Testing of Bistable Lattices with Tensegrity Architecture and Nanoscale Features Fabricated by Multiphoton Lithography.
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 48 citations in OpenAlex.
- Precision Stress Engineering in Tensegrity-Inspired Nanoarchitectures Enabled by Size-Affected Shrinkage.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Analysis of 3D printed longitudinal Flatfoot pads with lattice structures using various microfoaming filament.Scientific reports · 2026Article
- Engineering Metamaterials for Civil Infrastructure: From Acoustic Performance to Programmable Mechanical Responses.Materials (Basel, Switzerland) · 2025Review
- Review
- Multiscale Innovative Materials and Structures (MIMS).Nanomaterials (Basel, Switzerland) · 2021Article
- Active Control of Stiffness of Tensegrity Plate-like Structures Built with Simplex Modules.Materials (Basel, Switzerland) · 2021Article
- Additive Manufacture of Small-Scale Metamaterial Structures for Acoustic and Ultrasonic Applications.Micromachines · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
Abstract
A bistable response is an innate feature of tensegrity metamaterials, which is a conundrum to attain in other metamaterials, since it ushers unconventional static and dynamical mechanical behaviors. This paper investigates the design, modeling, fabrication and testing of bistable lattices with tensegrity architecture and nanoscale features. First, a method to design bistable lattices tessellating tensegrity units is formulated. The additive manufacturing of these structures is performed through multiphoton lithography, which enables the fabrication of microscale structures with nanoscale features and extremely high resolution. Different modular lattices, comprised of struts with 250 nm minimum radius, are tested under loading-unloading uniaxial compression nanoindentation tests. The compression tests confirmed the activation of the designed bistable twisting mechanism in the examined lattices, combined with a moderate viscoelastic response. The force-displacement plots of the 3D assemblies of bistable tensegrity prisms reveal a softening behavior during the loading from the primary stable configuration and a subsequent snapping event that drives the structure into a secondary stable configuration. The twisting mechanism that characterizes such a transition is preserved after unloading and during repeated loading-unloading cycles. The results of the present study elucidate that fabrication of multistable tensegrity lattices is highly feasible via multiphoton lithography and promulgates the fabrication of multi-cell tensegrity metamaterials with unprecedented static and dynamic responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.